Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD

Implementing lung cancer screening: baseline results from a community-based ‘Lung Health Check’ pilot in deprived areas of Manchester

(2018) Phil A Crosbie et al.   THORAX

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease

(2018) H. Balata et al.   LUNG CANCER

Second round results from the Manchester ‘Lung Health Check’ community-based targeted lung cancer screening pilot

(2018) Phil A Crosbie et al.   THORAX

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency

(2017) Sonya Cressman et al.   Journal of Thoracic Oncology

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

(2017) Kate Brain et al.   THORAX

Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective

(2017) Jie Dai et al.   Oncotarget

Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study

(2017) Yunus Çolak et al.   Lancet Respiratory Medicine

Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study

(2016) Laura E. Labonté et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Screening for Chronic Obstructive Pulmonary Disease

(2016) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CT screening for lung cancer: Is the evidence strong enough?

(2016) J.K. Field et al.   LUNG CANCER

Case finding for chronic obstructive pulmonary disease in people attending long-term condition clinics in primary care

(2016) DMG Halpin et al.   Chronic Respiratory Disease

Determinants of Underdiagnosis of COPD in National and International Surveys

(2015) Bernd Lamprecht et al.   CHEST

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial

(2015) Noor Ali et al.   BMJ Open

The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening

(2014) F. E. McRonald et al.   Cancer Prevention Research

COPD phenotypes in a lung cancer screening population

(2014) Arzu Balkan et al.   Clinical Respiratory Journal

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts

(2014) Martin C. Tammemägi et al.   PLOS MEDICINE

Selection Criteria for Lung-Cancer Screening

(2013) Martin C. Tammemägi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group

(2013) Yasuo Sekine et al.   RESPIROLOGY

Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans

(2011) Onno M. Mets et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Participation bias in a randomised trial of screening for lung cancer

(2011) Mie Sara Hestbech et al.   LUNG CANCER

Baseline Characteristics of Participants in the Randomized National Lung Screening Trial

(2010) et al.   JNCI-Journal of the National Cancer Institute

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history

(2009) R. P. Young et al.   EUROPEAN RESPIRATORY JOURNAL

Prevalence, severity and underdiagnosis of COPD in the primary care setting

(2008) M Bednarek et al.   THORAX